$112M
in disclosed stock, −$6.4M (−5.40%) today
Live prices, last trade 3:34 PM ET
- Rank
- 1390th of 14,644
- Companies held
- 1
- Largest holding
- GENI, 100.0% of total
- Latest SEC filing
- Sep 17, 2026
What the $112M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Genius Sports GENI Ordinary Shares | Directly | 19,375,216 | $5.78 | $112M | 100.0% | Form 4, Sep 17, 2026 |
Share counts are the amounts Mark Locke reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1387 | Charles V Bergh Executive Vice Chair, Levi Strauss &. Oakland, CA | $112M |
| 1388 | James R. Brickman Chief Executive Officer, Green Brick Partners. Plano, TX | $112M |
| 1389 | Jan Philipp Jenisch Chairman & CEO, Amrize | $112M |
| 1390 | Mark Locke Chief Executive Officer, Genius Sports | $112M |
| 1391 | J. Erik Fyrwald Director, Eli Lilly and. Indianapolis, IN | $112M |
| 1392 | Robert Gregory Kidd CEO, President, Chairman, USBC. Seattle, WA | $112M |
| 1393 | George W. LeMaitre Chairman and CEO, LeMaitre Vascular. Burlington, MA | $112M |
Other Genius Sports insiders
All GENI insiders- Jack Davison$11.6MChief Commercial Officer. #7886 overall
- Bryan Castellani$641KChief Financial Officer. #14269 overall
Questions
How much stock does Mark Locke own?
Mark Locke holds $111,988,748 in listed stock based on SEC filings and current prices, mostly Genius Sports (GENI). That ranks 1390th on the Stock Rich List.
Is this Mark Locke's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark Locke last buy or sell stock?
The most recent open-market trade on file is a sale of 50,000 GENI shares on Sep 17, 2026 at $6.54.